Transcripts HK inno.N Corporation

Equities

End-of-day quote Korea S.E. Other stock markets 03:30:00 21/05/2024 am IST			5-day change	1st Jan Change
38,050 ^KRW	-1.42%		-0.52%	-14.40%

2022	Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights from HK inno.N Corporation to Develop and Commercialize Tegoprazan in the U.S. and Canada	CI
2022	Sebela Pharmaceuticals Enters an Exclusive Partnership with HK inno.N Corporation	CI

No results for this search